Health

Coronavirus 14-10-2020

The Brief, powered by logos – Back to square one?

The COVID-19 crisis is back at full speed, with a steady stream of incoming news about new risk areas and regions, new quarantine measures and curfews. We’ve been there, done that, but is there anything new in all of this?...
Coronavirus 14-10-2020

To overcome COVID-19, we need to show leadership on seasonal flu vaccination

As we approach the 2020-2021 winter season, we are facing a potential “twindemic” of COVID-19 and seasonal flu. That is why we need to show strong political leadership and take concrete policy measures to secure seasonal flu vaccine uptake, writes MEP Dolors Montserrat.
Politics 08-10-2020

Better future for the Euro-Mediterranean region continues to inspire

Twenty-five years ago, the Barcelona Process was launched in an effort to construct a zone of shared prosperity around the Euro-Mediterranean area. President of the Committee of the Regions Apostolos Tzitzikostas looks at the progress made and challenges left to overcome.
Economy & Jobs 01-10-2020

Science and Innovation as the way out of the crisis

The only plausible exit strategy for our current global challenges is science and innovation. We need EU funding for science and innovation more than ever… yet the Council wants to cut Horizon Europe, warn Pascal Lamy and Carlos Moedas.
Coronavirus 30-09-2020

The biggest challenge for COVID-19 vaccines is the cold supply chain

Medical authorities and governments around the world should not only embrace one or more of the approved COVID-19 vaccines but must also be ready for the logistics of delivery, which includes a gigantic cold chain, possibly for temperatures as low...

Medical advice to EU leaders: prevention comes before cure

The EU’s recovery package is the not-to-be-missed opportunity to lead us to a healthier future and should not extend a lifeline to the pollution that is making us sick, writes Peter van den Hazel.
Special ReportPromoted content
24-09-2020

If you are serious about health, you should be serious about nutrition

Nutrition and nutritional care are eminently (cost) effective interventions and should therefore be a key component and integral part of any EU health initiative that strives for disease prevention, effective treatment and improved patient outcomes. Olle Ljungqvist is Professor of...
Stakeholder Opinion
Coronavirus 17-09-2020

COVID-19 vaccines: Why safety always comes first

The news that clinical trials of one of the candidate vaccines against COVID-19 had been halted may have caused hearts to sink. In reality, it underlined the priority commitment to the safety of everyone involved in fighting the coronavirus, writes Nathalie Moll.
Coronavirus 14-09-2020

COVID-19: Time to show citizens that they can count on Europe

European citizens have been exemplary in their fight against COVID 19. They have bravely overcome an acute sanitary threat and paid the high economic, social and psychological price of the lockdown, write a group of European lawmakers.
11-09-2020

EU health programme needs proper funding to be ready for present and future challenges

The ambitious new EU4Health programme needs adequate funding if we really want it to be efficient and reach its goal to protect citizens’ health in the years to come, write three European lawmakers. Véronique Trillet-Lenoir, Nicolae Ștefănuță are MEPs from the...
Coronavirus 10-09-2020

The Brief, powered by amfori – Rush to promise vaccines is foolish at best

As news broke on Tuesday that trials on one of the leading contenders for a COVID-19 vaccine have been paused over a potential health risk, leaders around the world are still scrambling to offer false hope and promises. Between US...
Stakeholder Opinion
09-09-2020

Revisiting the use and management of blood in Europe, in times of crisis and beyond

Anaemia is the world’s most prevalent disorder with more than 2.4 billion people affected. Evidence is mounting that anaemia has a negative impact on medical and surgical outcomes contributing to increased rates of morbidity, mortality and hospital length of stay.
Special ReportPromoted content
08-09-2020

A new start for healthcare systems

The COVID-19 crisis has put the resilience and agility of European health systems to the test in an unprecedented way, and has reminded us about the crucial importance of health and wellbeing for our societies. Nathalie Moll is the Director...
Coronavirus 03-09-2020

The Brief – Treaties over common-sense?

MEPs have packed their bags, ready to get back to Strasbourg after a forced six-month hiatus. But moving the entire EU circus to another country may not be the brightest idea right now. In an unprecedented move, European Parliament President...
Coronavirus 24-08-2020

The Brief – On to next season

Life in a COVID-19 world may be hard to recognise but there are some norms that even COVID-19 can’t change. The adage that football is played by two teams and, at the end, the Germans win, was confirmed by Sunday’s...
Coronavirus 19-08-2020

Is there a link between air pollution and the coronavirus?

Early signs suggest the spread of COVID-19 is facilitated by air pollution, and if so, why not clean the air by using alternative fuels, such as ethanol?, writes Angela Tin and Zoltán Szabó. Angela Tin is from the American Lung...
Coronavirus 24-07-2020

The Brief – Breaking (for) summer

This summer will be different. Travelling in the time of COVID-19 is not a pleasure, even inside Europe, and especially if you live in the EU and want to go to another continent. Intercontinental travel has almost completely stopped, only...
Special ReportPromoted content
24-07-2020

Europe at the crossroad of Rare Diseases innovation: lessons from the past and future outlooks

In shaping the future of rare diseases policies all stakeholders should cooperate to create an environment that actively supports research and clinical development of orphan medicinal products (OMPs). This entails building synergies all across the innovation ecosystem to address the...
Special ReportPromoted content
13-07-2020

The complexity of R&D for orphan medicines

There are multiple challenges inherent to drug development for rare diseases, all consequences of the small number of patients. For most of these diseases, the body of pre-existing knowledge is extremely limited with a lack of crucial information such as...
Special ReportPromoted content
10-07-2020

From pandemic to rare disease, medical innovation is the answer

Living through a global pandemic, we can take some comfort from the enormous collaborative research and development response that is taking place to find a way out from under the shadow of the COVID-19 crisis. Scientists around the world are...

EU’s trade deals can put an end to deforestation

The EU must take an aggressive “stick and carrot” approach to trade deals in order to put an end to deforestation and avert a next pandemic, writes Fazlun Khalid.
09-07-2020

Taking action on the global threat of superbugs

COVID-19 has demonstrated in a quite dramatic way the huge impact of a global threat on public health and economy. While the COVID-19 crisis took us by surprise, our world faces a silent threat that is predictable and preventable, writes Hubertus Von Baumbach, the CEO of pharmaceutical company Boehringer Ingelheim.
Coronavirus 08-07-2020

The Brief, powered by BSEF – The price of delay

Boris Johnson’s UK government has been widely flayed, quite rightly, for its response to the COVID-19 pandemic. Slow to lockdown and slow to test and trace, the result is the highest death toll in Europe. But Johnson and his Finance...
Promoted content
29-06-2020

A call to Germany’s EU Council Presidency: Strengthen Europe’s pandemic response workforce

Why a professionalised trained pest management sector can help better prepare for future health crises while contributing to sustainability goals, reconciling both short-term and long-term objectives of the German Presidency.
Contribute